October 23, 2015 News by Charles Moore Cannabis-Derived Sativex for MS-Related Spasticity Reported to Be Effective and Safe Barcelona, Spain-based, global pharma firm Almirall presented new clinical evidence at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) ā held in Barcelona October 7ā10, 2015 ā supporting the efficacy of its Sativex product, currently the only pharmaceutical medicine derived from cannabinoids…
September 24, 2015 News by Patricia Silva, PhD Medical Marijuana Use for Pain Relief in Medical Conditions like MS and AIDS Explored in New Nature Article Cannabis is a plant that can be usedĀ in a wide range ofĀ settings such as medical purposes, a source of fiber and oils, or as a recreational drug. Growing evidence has been reported on the clinical benefits of medical marijuana (herbal form) for treating chronic pain. Currently, several countries in the…
August 26, 2015 News by Patricia Silva, PhD Clinical Studies of Cannabinoid Capsules for MS Expected Later This Year Multiple sclerosis (MS) is a disease characterized by the destruction of insulating covers on nerve cells by the immune system. The most common form for the disease, relapsing-remitting MS, is characterized by clearly defined attacks of decreasing neurologic function (relapses) followed by partial or complete recovery…
August 12, 2015 News by Charles Moore Could Multiple Sclerosis Sufferers Benefit From Cannabis Chewing Gum? AXIM Biotechnologies, Inc., a biotechnology company focused on global research, development and production of pharmaceutical, nutraceutical, food and cosmetic products derived from industrial hemp, has announced commencement of clinical development of its leading patented pharmaceutical chewing gum, MedChew RX, for registration as a drug for relieving pain and/or spasticity…
June 12, 2015 News by Charles Moore Most MS Survey Respondents Favor Legal Marijuana Access For Medical Use With 26 statesĀ plus the District of Columbia now allowing medical marijuana use, according to a recent North American Research Committee on Multiple Sclerosis (NARCOMS) survey, many people with multiple sclerosis are considering the herb as a therapeutic option. NARCOMS is a research program that allows people with Multiple Sclerosis…
February 9, 2015 News by Charles Moore Leading Developer Of Cannabis-Based Therapeutics Nemus To Address MS, Other Unmet Medical Needs The 2012 and 2014 ballots approving legalization of cannabis in four U.S. states have stirred the pot, so to speak, on a wide range of issues and nuances related to the herb — not least marijuana’s clinical use as a therapeutic agent. Medical marijuana remains a topic of debate…
August 18, 2014 News by Charles Moore Wales First U.K. Country To Approve Cannabis-Based Medicine for MS Patients Welsh health minister Mark Drakeford has announced that Wales has become the first UK country to authorize a cannabis-based medicine under its National Health Service. Sativex, a proprietary oral spray cannabinoid medicine that has been licensed in the UK to treat muscle spasms and stiffness in people…